These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2328 related items for PubMed ID: 12783009

  • 1. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY, Tufaro AP, Manson PN.
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [Abstract] [Full Text] [Related]

  • 2. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R, Bril H, van der Loo EM, de Graaf PW.
    Ned Tijdschr Geneeskd; 2004 May 01; 148(18):884-8. PubMed ID: 15152391
    [Abstract] [Full Text] [Related]

  • 3. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.
    Ann Surg Oncol; 2006 Dec 01; 13(12):1655-63. PubMed ID: 17016755
    [Abstract] [Full Text] [Related]

  • 4. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.
    Arch Dermatol; 2008 Apr 01; 144(4):462-7. PubMed ID: 18427039
    [Abstract] [Full Text] [Related]

  • 5. [Sentinel lymph node biopsy in patients with melanoma].
    Tomás-Mallebrera L, Rojo-España R, Marquina-Vila A, Gimeno-Clemente N, Morales-Suárez-Varela MM.
    Actas Dermosifiliogr; 2010 Jun 01; 101(5):428-36. PubMed ID: 20525486
    [Abstract] [Full Text] [Related]

  • 6. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI, Rutkowski P, Michej W.
    Ann Surg Oncol; 2008 Aug 01; 15(8):2223-34. PubMed ID: 18506535
    [Abstract] [Full Text] [Related]

  • 7. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.
    J Am Acad Dermatol; 2001 May 01; 44(5):762-6. PubMed ID: 11312421
    [Abstract] [Full Text] [Related]

  • 8. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.
    Arch Dermatol; 2009 Oct 01; 145(10):1105-13. PubMed ID: 19841396
    [Abstract] [Full Text] [Related]

  • 9. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.
    Homolak D, Vucetić B, Puljiz Z, Blajć I, Vurnek Zivković M, Situm M.
    Coll Antropol; 2008 Oct 01; 32 Suppl 2():57-60. PubMed ID: 19138008
    [Abstract] [Full Text] [Related]

  • 10. [Tumour regression is not predictive for higher risk of sentinel node involvement in thin melanomas (Breslow thickness < or = 1 mm)].
    Kramkimel N, Maubec E, Boitier F, Cavalcanti A, Beldi M, Mamelle G, Kolb F, Duvillard P, Avril MF.
    Ann Dermatol Venereol; 2010 Apr 01; 137(4):276-80. PubMed ID: 20417360
    [Abstract] [Full Text] [Related]

  • 11. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR.
    Cancer; 2010 Mar 15; 116(6):1535-44. PubMed ID: 20108306
    [Abstract] [Full Text] [Related]

  • 12. Tumour regression does not increase the risk of sentinel node involvement in thin melanomas.
    Cecchi R, Pavesi M, Buralli L, Innocenti S, De Gaudio C.
    Chir Ital; 2008 Mar 15; 60(2):257-60. PubMed ID: 18689175
    [Abstract] [Full Text] [Related]

  • 13. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy.
    Zapas JL, Coley HC, Beam SL, Brown SD, Jablonski KA, Elias EG.
    J Am Coll Surg; 2003 Sep 15; 197(3):403-7. PubMed ID: 12946795
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
    Sartore L, Papanikolaou GE, Biancari F, Mazzoleni F.
    Int J Surg; 2008 Jun 15; 6(3):205-9. PubMed ID: 18417434
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S.
    Cancer; 2001 Jun 15; 91(12):2401-8. PubMed ID: 11413531
    [Abstract] [Full Text] [Related]

  • 17. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I, Talve L, Vihinen P, Mäki M, Vahlberg T, Suominen E.
    Ann Surg Oncol; 2007 Dec 15; 14(12):3566-74. PubMed ID: 17924169
    [Abstract] [Full Text] [Related]

  • 18. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M, Allison A, Shimoni T, Uchida T, Raimer S, Kelly B.
    J Am Acad Dermatol; 2009 Nov 15; 61(5):819-28. PubMed ID: 19836642
    [Abstract] [Full Text] [Related]

  • 19. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL.
    Am J Surg; 2005 Aug 15; 190(2):196-9. PubMed ID: 16023430
    [Abstract] [Full Text] [Related]

  • 20. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
    Gajdos C, Griffith KA, Wong SL, Johnson TM, Chang AE, Cimmino VM, Lowe L, Bradford CR, Rees RS, Sabel MS.
    Cancer; 2009 Dec 15; 115(24):5752-60. PubMed ID: 19827151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 117.